259 related articles for article (PubMed ID: 31361020)
1. Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.
Ferraro L; La Cascia C; Quattrone D; Sideli L; Matranga D; Capuccio V; Tripoli G; Gayer-Anderson C; Morgan C; Sami MB; Sham P; de Haan L; Velthorst E; Jongsma HE; Kirkbride JB; Rutten BPF; Richards AL; Roldan L; Arango C; Bernardo M; Bobes J; Sanjuan J; Santos JL; Arrojo M; Tarricone I; Tortelli A; Szöke A; Del-Ben CM; Selten JP; Lynskey M; Jones PB; Van Os J; La Barbera D; ; Murray RM; Di Forti M
Schizophr Bull; 2020 Apr; 46(3):517-529. PubMed ID: 31361020
[TBL] [Abstract][Full Text] [Related]
2. Cannabis users have higher premorbid IQ than other patients with first onset psychosis.
Ferraro L; Russo M; O'Connor J; Wiffen BD; Falcone MA; Sideli L; Gardner-Sood P; Stilo S; Trotta A; Dazzan P; Mondelli V; Taylor H; Friedman B; Sallis H; La Cascia C; La Barbera D; David AS; Reichenberg A; Murray RM; Di Forti M
Schizophr Res; 2013 Oct; 150(1):129-35. PubMed ID: 23958486
[TBL] [Abstract][Full Text] [Related]
3. First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data.
Ferraro L; Quattrone D; La Barbera D; La Cascia C; Morgan C; Kirkbride JB; Cardno AG; Sham P; Tripoli G; Sideli L; Seminerio F; Sartorio C; Szoke A; Tarricone I; Bernardo M; Rodriguez V; Stilo SA; Gayer-Anderson C; de Haan L; Velthorst E; Jongsma H; Bart RBP; Richards A; Arango C; Menezez PR; Lasalvia A; Tosato S; Tortelli A; Del Ben CM; Selten JP; Jones PB; van Os J; ; Di Forti M; Vassos E; Murray RM
Schizophr Bull; 2023 Jan; 49(1):218-227. PubMed ID: 35947471
[TBL] [Abstract][Full Text] [Related]
4. Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
Pauselli L; Birnbaum ML; Vázquez Jaime BP; Paolini E; Kelley ME; Broussard B; Compton MT
Schizophr Res; 2018 Jul; 197():544-549. PubMed ID: 29397281
[TBL] [Abstract][Full Text] [Related]
5. IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.
Ferraro L; Murray RM; Di Forti M; Quattrone D; Tripoli G; Sideli L; La Barbera D; La Cascia C
Schizophr Res; 2019 Aug; 210():81-88. PubMed ID: 31272907
[TBL] [Abstract][Full Text] [Related]
6. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
7. Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition.
Ayesa-Arriola R; Setién-Suero E; Neergaard KD; Belzunces ÀA; Contreras F; van Haren NEM; Crespo-Facorro B
Schizophr Res; 2018 Jul; 197():370-377. PubMed ID: 29275855
[TBL] [Abstract][Full Text] [Related]
8. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.
Leeson VC; Harrison I; Ron MA; Barnes TR; Joyce EM
Schizophr Bull; 2012 Jun; 38(4):873-80. PubMed ID: 21389110
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-potency cannabis on corpus callosum microstructure.
Rigucci S; Marques TR; Di Forti M; Taylor H; Dell'Acqua F; Mondelli V; Bonaccorso S; Simmons A; David AS; Girardi P; Pariante CM; Murray RM; Dazzan P
Psychol Med; 2016 Mar; 46(4):841-54. PubMed ID: 26610039
[TBL] [Abstract][Full Text] [Related]
10. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
[TBL] [Abstract][Full Text] [Related]
11. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.
Compton MT; Broussard B; Ramsay CE; Stewart T
Schizophr Res; 2011 Mar; 126(1-3):71-6. PubMed ID: 21036542
[TBL] [Abstract][Full Text] [Related]
12. Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores.
Monte RC; Goulding SM; Compton MT
Schizophr Res; 2008 Sep; 104(1-3):206-13. PubMed ID: 18657952
[TBL] [Abstract][Full Text] [Related]
13. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of neurocognition in young psychosis patients with current cannabis use.
Bogaty SER; Lee RSC; Hickie IB; Hermens DF
J Psychiatr Res; 2018 Apr; 99():22-32. PubMed ID: 29407284
[TBL] [Abstract][Full Text] [Related]
16. Premorbid characteristics of patients with DSM-IV psychotic disorders.
Widing L; Simonsen C; Flaaten CB; Haatveit B; Vik RK; Wold KF; Åsbø G; Ueland T; Melle I
Compr Psychiatry; 2022 May; 115():152310. PubMed ID: 35385814
[TBL] [Abstract][Full Text] [Related]
17. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
[TBL] [Abstract][Full Text] [Related]
18. Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
Cuesta MJ; Sánchez-Torres AM; Cabrera B; Bioque M; Merchán-Naranjo J; Corripio I; González-Pinto A; Lobo A; Bombín I; de la Serna E; Sanjuan J; Parellada M; Saiz-Ruiz J; Bernardo M;
Schizophr Res; 2015 May; 164(1-3):65-73. PubMed ID: 25819935
[TBL] [Abstract][Full Text] [Related]
19. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
[TBL] [Abstract][Full Text] [Related]
20. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
